Skip to main content
Grow & Thrive Wellness
The year I stopped skipping checkups, and what a proper preventive health screen actually catches.
Preventive health screening and the checks that are worth your time.

Kidney and Liver Function Tests: What These Blood Panels Actually Show

By Marisol Quintero  |  Medically reviewed by Dr Aaron Vandermeer, MD, MD

Published April 9, 2026 · Last reviewed April 17, 2026

Key takeaways

  • A kidney panel centres on creatinine and an estimated GFR (eGFR), reported with electrolytes, to gauge how well the kidneys filter blood.
  • A liver panel (LFTs) reports enzymes such as ALT, AST, and ALP, plus bilirubin and albumin, which together describe liver injury, blockage, and capacity to make proteins.
  • Both panels are pattern tests, not single-number verdicts: one mildly out-of-range value in a person with no symptoms is common and often resolves on a repeat.
  • Many shifts have ordinary explanations such as hydration, muscle mass, a recent meal, alcohol, or a new medication, which is why context and a repeat draw matter.
  • These tests screen for largely silent conditions; early chronic kidney disease and early liver disease often cause no symptoms at all.

Kidney and liver function tests rarely confirm disease by themselves; they are early, mostly silent signals that a clinician reads as a pattern over time, not as a pass-or-fail line on a single printout. That distinction is the whole point of including them in a routine checkup, because the conditions they catch tend to cause no symptoms until they are advanced.

The first time I saw “ALT” flagged on my own results, I went looking for the worst-case meaning before I understood that a mildly raised enzyme in a symptom-free adult is one of the most ordinary findings a laboratory produces. The nurse who reviewed it did not order a scan or a referral. She asked about the previous evening, suggested a repeat draw in a few weeks, and the number had drifted back into range by then. That sequence, notice, contextualise, repeat, is how these panels are meant to work.

What a kidney function panel measures

A kidney panel centres on two linked numbers: creatinine and the estimated glomerular filtration rate (eGFR), usually reported alongside electrolytes such as sodium and potassium.1 Creatinine is a waste product from normal muscle activity that healthy kidneys clear steadily. When filtering slows, creatinine builds up, so a rising creatinine is an indirect measure of how well the kidneys are working.

eGFR translates that creatinine value into a more intuitive figure by combining it with your age and sex to estimate how much blood your kidneys filter per minute. Because the estimate leans on muscle-derived creatinine, things unrelated to kidney disease can move it: dehydration, a very high or very low muscle mass, and some medications all shift the reading. This is why one low eGFR is treated as a flag rather than a diagnosis, and why interpreting it follows the same context-first logic as reading any blood test result.

What a liver function panel measures

A liver panel, often labelled LFTs, is really a small group of tests describing three different things at once: injury, blockage, and the liver’s ability to make proteins.2 The enzymes ALT and AST leak from liver cells when those cells are stressed or damaged, so they rise with conditions like fatty liver, alcohol, viral hepatitis, and some medications. ALP and a related enzyme tend to rise when bile flow is obstructed rather than when liver cells themselves are injured.

The other two core values describe function rather than damage. Bilirubin is a pigment the liver normally processes and clears; when it rises it can signal a problem with that processing or with bile drainage, and at higher levels it produces visible jaundice. Albumin is a protein the liver manufactures, so a low albumin can reflect reduced liver capacity (among other causes). Reading these together, which enzymes are up, whether bilirubin is involved, whether albumin has fallen, is what turns five separate numbers into a recognisable pattern.

Why a single abnormal value is so common

These are pattern tests, and isolated mild abnormalities in symptom-free people are frequent and often meaningless on their own. A clinician looks at the degree of the change, whether several related values move together, your symptoms, and your history before deciding anything. A creatinine nudged up after a hot day with little fluid, or an ALT raised the day after intense exercise, can both normalise on a repeat without any treatment.

The honest framing is that more testing is not automatically safer. Casting a wide net in healthy people inevitably produces borderline results that need a repeat or a recheck, and the most useful next step after a single mild flag is frequently a second blood draw rather than a cascade of scans. This is the same principle that runs through sensible prevention, and it sits alongside blood pressure screening and diabetes screening as part of a wider cardiometabolic picture, since high blood pressure and high blood sugar are leading drivers of kidney damage over time.

Why these tests are worth doing at all

The case for including them is that early kidney and liver disease are largely silent. Chronic kidney disease commonly produces no symptoms in its earlier stages and is often picked up only through routine bloods, yet it is defined and staged precisely so it can be monitored and slowed before it advances.3 Early liver disease behaves similarly, with fatty liver in particular often discovered through an incidental enzyme rise rather than any complaint from the patient.

Both organs are also caught up in the wider burden of noncommunicable disease. Kidney and liver conditions are influenced by the same modifiable factors, blood pressure, blood sugar, weight, alcohol, that drive much of the world’s chronic illness, and addressing those factors is central to prevention.4 That is why these panels earn a place in a checkup: not to deliver a verdict from one number, but to surface a quiet trend early enough to act on.

What happens after an abnormal result

An out-of-range value starts a conversation, not a treatment. Depending on which value moved and by how much, a clinician may repeat the test, look at the specific pattern, ask about alcohol and medications, or arrange further assessment such as an ultrasound or additional blood tests. Persistence matters: chronic kidney disease is defined by reduced filtration or damage markers lasting at least three months, so confirmation deliberately requires more than a single reading.1

Where lifestyle plays a role, the levers differ by organ. Liver enzyme rises tied to fatty liver often improve with reduced alcohol, weight loss, and better blood-sugar control, while protecting kidney function leans more on managing blood pressure and diabetes and avoiding unnecessary kidney-stressing drugs. How much any of this shifts the numbers depends entirely on the underlying cause, which is the reason these results belong in a discussion with a clinician who knows your history rather than in a self-diagnosis from a printout.

This article is general information, not medical advice. For your own results, repeat intervals, and any treatment, see a qualified clinician who knows your history.

References

  1. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, Kidney Disease: Improving Global Outcomes (KDIGO).
  2. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries, American College of Gastroenterology.
  3. Chronic kidney disease: assessment and management (NG203), National Institute for Health and Care Excellence.
  4. Noncommunicable diseases, World Health Organization.

Common questions

Do I need to fast before a kidney or liver blood test?

Often you do not for the kidney and liver values themselves, but fasting is sometimes requested when the same blood draw also checks glucose or lipids. A recent large or fatty meal can nudge some results slightly. Follow the specific instruction your testing service gives, because protocols differ by laboratory and panel.

What does a low eGFR mean?

A single low eGFR is a flag, not a diagnosis. eGFR is estimated from creatinine, age, and sex, and it can dip temporarily with dehydration, illness, or certain medications. Chronic kidney disease is defined by a reduced eGFR or kidney damage markers persisting for at least three months, so a clinician confirms it with a repeat test rather than one reading.

Are slightly raised liver enzymes serious?

Usually a mild rise is not an emergency, and mildly abnormal liver enzymes are common in symptom-free adults. Common causes include fatty liver, alcohol, some medications, and recent vigorous exercise. A clinician decides whether to simply repeat the test, look at the pattern of which enzymes are raised, or investigate further.

How often should these tests be repeated?

There is no single universal interval. People with diabetes, high blood pressure, known kidney or liver conditions, or those on medications that affect these organs are usually monitored on a schedule set by their clinician. For healthy adults without risk factors, these panels are typically done as part of a wider checkup rather than on a fixed personal timetable.

Can I improve these results with lifestyle changes?

Sometimes, particularly for the liver. Reducing alcohol, reaching a healthy weight, and treating conditions like diabetes can improve fatty-liver-related enzyme rises. Kidney results respond more to managing blood pressure, blood sugar, and avoiding unnecessary kidney-stressing medications. How much changes depends on the cause, and some causes are structural rather than reversible.

Written by Marisol Quintero. Medically reviewed by Dr Aaron Vandermeer, MD, MD.

Our guides are written from personal experience and reviewed by a qualified clinician for accuracy. Read our editorial policy.

More from us